Colin Shearn
Concepts (298)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholestasis | 10 | 2023 | 232 | 3.690 |
Why?
| | Aldehydes | 15 | 2022 | 145 | 3.360 |
Why?
| | Liver | 22 | 2025 | 1940 | 2.930 |
Why?
| | Protein Carbonylation | 10 | 2018 | 54 | 2.630 |
Why?
| | PTEN Phosphohydrolase | 7 | 2018 | 162 | 2.590 |
Why?
| | Liver Diseases, Alcoholic | 12 | 2019 | 93 | 2.550 |
Why?
| | Bile Acids and Salts | 7 | 2024 | 200 | 2.220 |
Why?
| | Ethanol | 12 | 2019 | 606 | 1.870 |
Why?
| | Glutathione Transferase | 8 | 2019 | 105 | 1.710 |
Why?
| | Antioxidants | 7 | 2023 | 584 | 1.700 |
Why?
| | Cholangitis, Sclerosing | 4 | 2024 | 75 | 1.650 |
Why?
| | Parenteral Nutrition | 5 | 2024 | 107 | 1.400 |
Why?
| | Proto-Oncogene Proteins c-akt | 6 | 2016 | 437 | 1.390 |
Why?
| | Oxidative Stress | 14 | 2019 | 1314 | 1.240 |
Why?
| | Ileum | 2 | 2024 | 119 | 1.070 |
Why?
| | Fatty Liver | 3 | 2014 | 243 | 1.060 |
Why?
| | Mice, Inbred C57BL | 17 | 2025 | 5749 | 0.980 |
Why?
| | Tumor Necrosis Factor-alpha | 5 | 2024 | 1242 | 0.950 |
Why?
| | Inflammatory Bowel Diseases | 3 | 2020 | 351 | 0.950 |
Why?
| | Fatty Liver, Alcoholic | 2 | 2016 | 15 | 0.930 |
Why?
| | Mice | 37 | 2025 | 17757 | 0.920 |
Why?
| | Signal Transduction | 11 | 2024 | 5076 | 0.890 |
Why?
| | Thioredoxins | 3 | 2018 | 30 | 0.860 |
Why?
| | Carcinoma, Hepatocellular | 3 | 2019 | 361 | 0.770 |
Why?
| | Abdominal Injuries | 1 | 2023 | 123 | 0.760 |
Why?
| | AMP-Activated Protein Kinases | 2 | 2014 | 197 | 0.750 |
Why?
| | Protein Processing, Post-Translational | 4 | 2016 | 465 | 0.700 |
Why?
| | Animals | 39 | 2025 | 36847 | 0.690 |
Why?
| | Circadian Rhythm | 1 | 2024 | 469 | 0.670 |
Why?
| | Butylated Hydroxytoluene | 2 | 2011 | 38 | 0.650 |
Why?
| | Disease Models, Animal | 13 | 2025 | 4282 | 0.620 |
Why?
| | Hepatocytes | 5 | 2021 | 220 | 0.620 |
Why?
| | Peroxiredoxins | 2 | 2018 | 24 | 0.620 |
Why?
| | Thioredoxin-Disulfide Reductase | 1 | 2018 | 13 | 0.590 |
Why?
| | NF-E2-Related Factor 2 | 2 | 2019 | 93 | 0.590 |
Why?
| | Non-alcoholic Fatty Liver Disease | 3 | 2017 | 279 | 0.560 |
Why?
| | Gene Knockout Techniques | 1 | 2018 | 117 | 0.560 |
Why?
| | Hepatitis | 1 | 2017 | 48 | 0.550 |
Why?
| | Liver Diseases | 2 | 2021 | 311 | 0.540 |
Why?
| | Liver Cirrhosis | 3 | 2024 | 316 | 0.520 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 3 | 2024 | 219 | 0.520 |
Why?
| | Liver Neoplasms | 4 | 2019 | 785 | 0.520 |
Why?
| | Superoxide Dismutase | 5 | 2019 | 346 | 0.510 |
Why?
| | Mitochondrial Proteins | 2 | 2015 | 256 | 0.510 |
Why?
| | Chemical and Drug Induced Liver Injury, Chronic | 1 | 2016 | 12 | 0.510 |
Why?
| | End Stage Liver Disease | 1 | 2017 | 82 | 0.500 |
Why?
| | Thioredoxin Reductase 1 | 3 | 2023 | 8 | 0.500 |
Why?
| | Liver Cirrhosis, Alcoholic | 1 | 2015 | 17 | 0.490 |
Why?
| | Tandem Mass Spectrometry | 5 | 2022 | 532 | 0.470 |
Why?
| | Alcoholism | 3 | 2018 | 804 | 0.450 |
Why?
| | ARNTL Transcription Factors | 2 | 2024 | 17 | 0.440 |
Why?
| | Oxidants | 2 | 2012 | 111 | 0.430 |
Why?
| | Diet, High-Fat | 2 | 2016 | 247 | 0.420 |
Why?
| | Mice, Knockout | 8 | 2020 | 3008 | 0.410 |
Why?
| | Male | 30 | 2025 | 67311 | 0.410 |
Why?
| | Dietary Fats | 2 | 2018 | 304 | 0.380 |
Why?
| | Lipid Peroxidation | 4 | 2016 | 153 | 0.370 |
Why?
| | RNA, Messenger | 6 | 2023 | 2831 | 0.360 |
Why?
| | Xenobiotics | 1 | 2011 | 32 | 0.350 |
Why?
| | Hydrogen Peroxide | 1 | 2012 | 327 | 0.340 |
Why?
| | Chromatography, Liquid | 4 | 2017 | 433 | 0.330 |
Why?
| | Oxidoreductases Acting on CH-CH Group Donors | 1 | 2010 | 26 | 0.330 |
Why?
| | Cell Proliferation | 3 | 2018 | 2475 | 0.330 |
Why?
| | Glutathione Reductase | 3 | 2019 | 25 | 0.330 |
Why?
| | Alcohol Drinking | 1 | 2016 | 820 | 0.310 |
Why?
| | Inflammation | 5 | 2023 | 2835 | 0.310 |
Why?
| | Mitochondria | 4 | 2019 | 946 | 0.300 |
Why?
| | Down-Regulation | 1 | 2011 | 656 | 0.300 |
Why?
| | Blotting, Western | 4 | 2016 | 1225 | 0.290 |
Why?
| | Carcinoma | 1 | 2010 | 238 | 0.290 |
Why?
| | Autophagy | 2 | 2022 | 280 | 0.280 |
Why?
| | Alcohol Oxidoreductases | 1 | 2008 | 62 | 0.280 |
Why?
| | Colonic Neoplasms | 1 | 2010 | 254 | 0.280 |
Why?
| | Carcinogens | 1 | 2008 | 124 | 0.280 |
Why?
| | Catalase | 2 | 2017 | 130 | 0.280 |
Why?
| | Phosphoric Monoester Hydrolases | 1 | 2007 | 54 | 0.260 |
Why?
| | NF-kappa B | 2 | 2021 | 691 | 0.260 |
Why?
| | Glutathione | 4 | 2019 | 356 | 0.250 |
Why?
| | Hep G2 Cells | 3 | 2021 | 67 | 0.240 |
Why?
| | Alanine Transaminase | 3 | 2016 | 157 | 0.240 |
Why?
| | Up-Regulation | 2 | 2019 | 844 | 0.240 |
Why?
| | Case-Control Studies | 3 | 2018 | 3539 | 0.230 |
Why?
| | Recombinant Proteins | 4 | 2020 | 1350 | 0.230 |
Why?
| | Protein Kinase Inhibitors | 1 | 2011 | 916 | 0.230 |
Why?
| | Gene Expression Regulation | 5 | 2021 | 2605 | 0.230 |
Why?
| | Enzyme Inhibitors | 1 | 2008 | 839 | 0.230 |
Why?
| | Humans | 27 | 2023 | 136765 | 0.220 |
Why?
| | Macrophage Activation | 2 | 2023 | 201 | 0.220 |
Why?
| | Ileitis | 1 | 2024 | 32 | 0.220 |
Why?
| | Biomarkers | 1 | 2015 | 4144 | 0.220 |
Why?
| | Proteomics | 4 | 2019 | 1109 | 0.210 |
Why?
| | Phosphorylation | 3 | 2014 | 1758 | 0.210 |
Why?
| | Epithelial Cells | 1 | 2010 | 1094 | 0.210 |
Why?
| | Genes, Regulator | 1 | 2023 | 37 | 0.210 |
Why?
| | Lipoproteins | 2 | 2021 | 168 | 0.210 |
Why?
| | Fibroblast Growth Factors | 1 | 2024 | 171 | 0.210 |
Why?
| | Cysteine Proteinase Inhibitors | 2 | 2014 | 49 | 0.200 |
Why?
| | Biliary Atresia | 1 | 2025 | 163 | 0.200 |
Why?
| | Sulfhydryl Compounds | 2 | 2018 | 189 | 0.200 |
Why?
| | Insulin Resistance | 1 | 2011 | 1203 | 0.190 |
Why?
| | Prostatic Neoplasms | 1 | 2010 | 1034 | 0.190 |
Why?
| | Fatty Acid-Binding Proteins | 2 | 2013 | 70 | 0.190 |
Why?
| | Enzyme Activation | 3 | 2013 | 810 | 0.190 |
Why?
| | Triglycerides | 2 | 2016 | 524 | 0.190 |
Why?
| | Mitochondria, Liver | 2 | 2013 | 73 | 0.190 |
Why?
| | Dioxanes | 1 | 2021 | 10 | 0.190 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2023 | 151 | 0.180 |
Why?
| | Isoxazoles | 1 | 2021 | 54 | 0.180 |
Why?
| | Phytosterols | 1 | 2021 | 12 | 0.180 |
Why?
| | Oxidation-Reduction | 3 | 2019 | 1059 | 0.180 |
Why?
| | Mucoproteins | 1 | 2020 | 10 | 0.170 |
Why?
| | Models, Molecular | 4 | 2014 | 1570 | 0.170 |
Why?
| | Phosphatidylinositol 4,5-Diphosphate | 1 | 2020 | 32 | 0.170 |
Why?
| | Cholesterol | 2 | 2020 | 410 | 0.170 |
Why?
| | Vesicular Transport Proteins | 1 | 2020 | 84 | 0.160 |
Why?
| | Phosphatidylcholines | 1 | 2020 | 147 | 0.160 |
Why?
| | Gene Expression | 2 | 2021 | 1500 | 0.160 |
Why?
| | Macrophages | 2 | 2025 | 1544 | 0.160 |
Why?
| | Cell Adhesion Molecules | 1 | 2020 | 181 | 0.160 |
Why?
| | Acylation | 1 | 2019 | 30 | 0.150 |
Why?
| | Liposomes | 1 | 2020 | 220 | 0.150 |
Why?
| | Lysosomes | 1 | 2019 | 141 | 0.150 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 2013 | 597 | 0.150 |
Why?
| | PPAR alpha | 2 | 2016 | 58 | 0.150 |
Why?
| | Female | 10 | 2025 | 72795 | 0.140 |
Why?
| | Mice, 129 Strain | 1 | 2018 | 88 | 0.140 |
Why?
| | Heme Oxygenase-1 | 1 | 2018 | 64 | 0.140 |
Why?
| | Sulfinic Acids | 1 | 2018 | 7 | 0.140 |
Why?
| | Colon | 1 | 2020 | 282 | 0.140 |
Why?
| | Ribosomes | 1 | 2019 | 186 | 0.140 |
Why?
| | Lung | 1 | 2011 | 4062 | 0.140 |
Why?
| | Aminobutyrates | 1 | 2018 | 35 | 0.140 |
Why?
| | Azo Compounds | 1 | 2017 | 30 | 0.140 |
Why?
| | Reactive Oxygen Species | 2 | 2011 | 621 | 0.140 |
Why?
| | Colitis | 1 | 2020 | 266 | 0.140 |
Why?
| | Taurine | 1 | 2018 | 46 | 0.140 |
Why?
| | Organ Specificity | 1 | 2018 | 304 | 0.140 |
Why?
| | Pyruvaldehyde | 1 | 2018 | 46 | 0.140 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2017 | 73 | 0.140 |
Why?
| | Protein Structure, Secondary | 1 | 2018 | 374 | 0.130 |
Why?
| | Gene Deletion | 2 | 2015 | 389 | 0.130 |
Why?
| | Homocystinuria | 1 | 2018 | 71 | 0.130 |
Why?
| | Malnutrition | 1 | 2018 | 82 | 0.130 |
Why?
| | Mice, Inbred BALB C | 2 | 2011 | 1269 | 0.130 |
Why?
| | Amino Acid Sequence | 4 | 2015 | 2138 | 0.130 |
Why?
| | Cell Line, Tumor | 3 | 2020 | 3405 | 0.120 |
Why?
| | Lipogenesis | 1 | 2016 | 61 | 0.120 |
Why?
| | Middle Aged | 4 | 2019 | 33228 | 0.120 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 98 | 0.120 |
Why?
| | Sirtuin 3 | 2 | 2019 | 61 | 0.120 |
Why?
| | Lysine | 1 | 2017 | 294 | 0.120 |
Why?
| | Adult | 4 | 2019 | 37631 | 0.110 |
Why?
| | Cytochrome P-450 CYP4A | 1 | 2014 | 4 | 0.110 |
Why?
| | Acetylation | 4 | 2017 | 248 | 0.110 |
Why?
| | CD36 Antigens | 1 | 2014 | 36 | 0.110 |
Why?
| | Proteome | 1 | 2019 | 472 | 0.110 |
Why?
| | Protein Isoforms | 1 | 2015 | 403 | 0.110 |
Why?
| | Central Nervous System Depressants | 1 | 2014 | 85 | 0.100 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2014 | 109 | 0.100 |
Why?
| | Heat-Shock Proteins | 1 | 2014 | 142 | 0.100 |
Why?
| | Phosphatidylinositol 3-Kinases | 2 | 2013 | 366 | 0.100 |
Why?
| | DNA Primers | 2 | 2012 | 514 | 0.100 |
Why?
| | Protein Binding | 4 | 2020 | 2216 | 0.100 |
Why?
| | Adenosine Triphosphatases | 1 | 2014 | 165 | 0.100 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2013 | 33 | 0.100 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2013 | 24 | 0.100 |
Why?
| | Carrier Proteins | 1 | 2017 | 769 | 0.100 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 1 | 2013 | 57 | 0.100 |
Why?
| | Molecular Sequence Data | 3 | 2015 | 2894 | 0.100 |
Why?
| | Computational Biology | 1 | 2017 | 643 | 0.100 |
Why?
| | Models, Chemical | 1 | 2014 | 263 | 0.100 |
Why?
| | Endoplasmic Reticulum | 2 | 2014 | 264 | 0.100 |
Why?
| | Polymerase Chain Reaction | 2 | 2016 | 1059 | 0.100 |
Why?
| | Organ Size | 1 | 2013 | 477 | 0.090 |
Why?
| | Reactive Nitrogen Species | 1 | 2011 | 21 | 0.090 |
Why?
| | Peptide Mapping | 1 | 2011 | 64 | 0.090 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2011 | 72 | 0.090 |
Why?
| | Adiponectin | 1 | 2013 | 244 | 0.090 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2011 | 82 | 0.090 |
Why?
| | Binding Sites | 2 | 2020 | 1301 | 0.090 |
Why?
| | Crotonates | 1 | 2010 | 5 | 0.080 |
Why?
| | Toluidines | 1 | 2010 | 7 | 0.080 |
Why?
| | Hydroxybutyrates | 1 | 2010 | 14 | 0.080 |
Why?
| | Fenretinide | 1 | 2010 | 4 | 0.080 |
Why?
| | Receptors, Estrogen | 1 | 2013 | 436 | 0.080 |
Why?
| | Tumor Cells, Cultured | 1 | 2012 | 953 | 0.080 |
Why?
| | Oxygen Consumption | 1 | 2013 | 695 | 0.080 |
Why?
| | Cell Line, Transformed | 1 | 2010 | 145 | 0.080 |
Why?
| | Microscopy, Confocal | 1 | 2011 | 324 | 0.080 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2011 | 177 | 0.080 |
Why?
| | Nitriles | 1 | 2010 | 172 | 0.080 |
Why?
| | Protein Conformation | 1 | 2012 | 933 | 0.080 |
Why?
| | Glycoproteins | 1 | 2011 | 342 | 0.080 |
Why?
| | Cell Survival | 1 | 2012 | 1116 | 0.070 |
Why?
| | Alkylation | 1 | 2008 | 26 | 0.070 |
Why?
| | Nuclear Proteins | 1 | 2013 | 712 | 0.070 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2008 | 180 | 0.070 |
Why?
| | Cytosol | 1 | 2008 | 226 | 0.070 |
Why?
| | RNA, Small Interfering | 1 | 2010 | 622 | 0.070 |
Why?
| | DNA Damage | 2 | 2021 | 420 | 0.070 |
Why?
| | Kidney | 1 | 2015 | 1467 | 0.070 |
Why?
| | Base Sequence | 1 | 2011 | 2179 | 0.070 |
Why?
| | Phosphatidylinositol Phosphates | 1 | 2007 | 39 | 0.070 |
Why?
| | Cells, Cultured | 2 | 2013 | 4191 | 0.070 |
Why?
| | Static Electricity | 1 | 2007 | 118 | 0.070 |
Why?
| | Hydrolysis | 1 | 2007 | 176 | 0.070 |
Why?
| | Immunohistochemistry | 1 | 2011 | 1733 | 0.060 |
Why?
| | Lung Neoplasms | 2 | 2011 | 2489 | 0.060 |
Why?
| | Cloning, Molecular | 2 | 2020 | 534 | 0.060 |
Why?
| | Amino Acid Substitution | 1 | 2007 | 306 | 0.060 |
Why?
| | Phospholipids | 1 | 2007 | 222 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 1 | 2011 | 2486 | 0.060 |
Why?
| | Skin | 1 | 2010 | 751 | 0.060 |
Why?
| | Peptides | 1 | 2011 | 980 | 0.060 |
Why?
| | Metabolome | 2 | 2019 | 350 | 0.060 |
Why?
| | Kupffer Cells | 1 | 2025 | 50 | 0.060 |
Why?
| | Transcription Factors | 1 | 2013 | 1718 | 0.060 |
Why?
| | Biomarkers, Tumor | 1 | 2011 | 1272 | 0.050 |
Why?
| | Glycosylation | 2 | 2016 | 151 | 0.050 |
Why?
| | Amino Acids | 2 | 2018 | 497 | 0.050 |
Why?
| | Rats | 1 | 2011 | 5639 | 0.050 |
Why?
| | Sterols | 1 | 2021 | 18 | 0.050 |
Why?
| | Multidrug Resistance-Associated Proteins | 1 | 2021 | 38 | 0.050 |
Why?
| | Systems Analysis | 1 | 2021 | 23 | 0.050 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 2 | 2012 | 114 | 0.050 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2021 | 87 | 0.050 |
Why?
| | Intestinal Diseases | 1 | 2021 | 42 | 0.050 |
Why?
| | Fatty Acids | 2 | 2016 | 442 | 0.050 |
Why?
| | Bilirubin | 1 | 2021 | 97 | 0.050 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2021 | 132 | 0.040 |
Why?
| | Infliximab | 1 | 2021 | 111 | 0.040 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2021 | 138 | 0.040 |
Why?
| | Protein Conformation, beta-Strand | 1 | 2020 | 17 | 0.040 |
Why?
| | Sphingomyelins | 1 | 2020 | 33 | 0.040 |
Why?
| | Apoptosis | 1 | 2010 | 2551 | 0.040 |
Why?
| | Ursodeoxycholic Acid | 1 | 2020 | 21 | 0.040 |
Why?
| | Calcium | 1 | 2007 | 1197 | 0.040 |
Why?
| | Phosphatidylinositols | 1 | 2020 | 57 | 0.040 |
Why?
| | Phosphatidylethanolamines | 1 | 2020 | 77 | 0.040 |
Why?
| | Phosphatidylserines | 1 | 2020 | 91 | 0.040 |
Why?
| | Dextran Sulfate | 1 | 2020 | 83 | 0.040 |
Why?
| | Molecular Docking Simulation | 1 | 2020 | 113 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2021 | 327 | 0.040 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2020 | 150 | 0.040 |
Why?
| | Lipid Bilayers | 1 | 2020 | 97 | 0.040 |
Why?
| | Interleukin-1beta | 1 | 2021 | 371 | 0.040 |
Why?
| | Genetic Vectors | 1 | 2020 | 317 | 0.040 |
Why?
| | Crystallography, X-Ray | 1 | 2020 | 476 | 0.040 |
Why?
| | Molecular Dynamics Simulation | 1 | 2020 | 211 | 0.040 |
Why?
| | Sirtuins | 1 | 2019 | 40 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2020 | 345 | 0.040 |
Why?
| | gamma-Glutamyltransferase | 1 | 2018 | 43 | 0.040 |
Why?
| | Aged | 1 | 2017 | 23794 | 0.040 |
Why?
| | Metabolic Networks and Pathways | 1 | 2019 | 180 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2025 | 1772 | 0.030 |
Why?
| | Cystathionine beta-Synthase | 1 | 2018 | 71 | 0.030 |
Why?
| | F2-Isoprostanes | 1 | 2016 | 21 | 0.030 |
Why?
| | Protein D-Aspartate-L-Isoaspartate Methyltransferase | 1 | 2016 | 5 | 0.030 |
Why?
| | Sumoylation | 1 | 2016 | 16 | 0.030 |
Why?
| | Escherichia coli | 1 | 2020 | 806 | 0.030 |
Why?
| | Oxides | 1 | 2016 | 46 | 0.030 |
Why?
| | Insulin-Secreting Cells | 1 | 2020 | 372 | 0.030 |
Why?
| | Methylation | 1 | 2016 | 230 | 0.030 |
Why?
| | Mutation | 1 | 2007 | 3946 | 0.030 |
Why?
| | Chemokine CXCL2 | 1 | 2014 | 43 | 0.030 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2014 | 29 | 0.030 |
Why?
| | Lipopolysaccharide Receptors | 1 | 2014 | 85 | 0.030 |
Why?
| | Oxidative Phosphorylation | 1 | 2015 | 193 | 0.030 |
Why?
| | Unfolded Protein Response | 1 | 2014 | 59 | 0.030 |
Why?
| | Matrix Metalloproteinases | 1 | 2014 | 95 | 0.030 |
Why?
| | Protein Folding | 1 | 2014 | 280 | 0.020 |
Why?
| | Antibodies | 1 | 2014 | 411 | 0.020 |
Why?
| | Anilino Naphthalenesulfonates | 1 | 2012 | 10 | 0.020 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2013 | 145 | 0.020 |
Why?
| | Actins | 1 | 2014 | 416 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2013 | 283 | 0.020 |
Why?
| | Ubiquitination | 1 | 2012 | 102 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2012 | 155 | 0.020 |
Why?
| | Fibrosis | 1 | 2014 | 551 | 0.020 |
Why?
| | Transforming Growth Factor beta | 1 | 2014 | 480 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2015 | 512 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2014 | 860 | 0.020 |
Why?
| | Disease Progression | 1 | 2019 | 2750 | 0.020 |
Why?
| | Microsomes, Liver | 1 | 2011 | 86 | 0.020 |
Why?
| | NAD | 1 | 2011 | 77 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2011 | 342 | 0.020 |
Why?
| | Transcriptome | 1 | 2016 | 969 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 975 | 0.020 |
Why?
| | Computer Simulation | 1 | 2014 | 973 | 0.020 |
Why?
| | Hypoxia | 1 | 2016 | 1112 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2012 | 738 | 0.020 |
Why?
| | Lipids | 1 | 2013 | 665 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2013 | 2163 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2013 | 1396 | 0.020 |
Why?
| | Cytokines | 1 | 2014 | 2084 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2013 | 2412 | 0.010 |
Why?
| | Adolescent | 1 | 2016 | 21382 | 0.010 |
Why?
| | Child | 1 | 2016 | 21819 | 0.010 |
Why?
|
|
Shearn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|